Sheng Su

CircRPN2 inhibits aerobic glycolysis and metastasis in hepatocellular carcinoma.

Jia Fan, Jian Zhou, Xiaowu Huang, 2022, Cancer research.

Development of Engineered CAR T Cells Targeting Tumor-Associated Glycoforms of MUC1 for the Treatment of Intrahepatic Cholangiocarcinoma

Zhi-qiang Hu, Jia Li, Changzhou Chen, 2023, Journal of immunotherapy.

Selective inhibition of HDAC6 promotes bladder cancer radiosensitization and mitigates the radiation-induced CXCL1 signalling

Y. Tsai, Y. Pu, J. Cheng, 2023, British Journal of Cancer.

LAYN Serves as a Prognostic Biomarker and Downregulates Tumor-Infiltrating CD8+ T Cell Function in Hepatocellular Carcinoma

Sheng Su, Weizhong Wu, Zhi-yuan Lin, 2024, Journal of hepatocellular carcinoma.

A Novel Protein Encoded by circFOXP1 Enhances Ferroptosis and Inhibits Tumor Recurrence in Intrahepatic Cholangiocarcinoma.

Sheng Su, Songyang Yu, Xinming Ye, 2024, Cancer letters.

Tumor-associated macrophage-induced circMRCKα encodes a peptide to promote glycolysis and progression in hepatocellular carcinoma.

Zhi-qiang Hu, Peng-Cheng Wang, Hezhi Wang, 2024, Cancer letters.